{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:17:26Z","timestamp":1791965846124,"version":"4.3.4"},"reference-count":125,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006348","name":"Collaboratory of AIDS Researchers for Eradication","doi-asserted-by":"publisher","award":["UM1 AI164560-01"],"award-info":[{"award-number":["UM1 AI164560-01"]}],"id":[{"id":"10.13039\/100006348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2141064"],"award-info":[{"award-number":["2141064"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["4R33AI161805-04"],"award-info":[{"award-number":["4R33AI161805-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2026490"],"award-info":[{"award-number":["2026490"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.celrep.2025.116545","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:53:30Z","timestamp":1763564010000},"page":"116545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV"],"prefix":"10.1016","volume":"44","author":[{"given":"Deepti","family":"Kannan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-0597","authenticated-orcid":false,"given":"Arup K.","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116545_bib1","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S2352-3018(23)00264-3","article-title":"Prophylactic HIV-1 vaccine trials: past, present, and future","volume":"11","author":"Nkolola","year":"2024","journal-title":"Lancet. HIV"},{"key":"10.1016\/j.celrep.2025.116545_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(10)60676-9","article-title":"Antiretroviral therapy and management of HIV infection","volume":"376","author":"Volberding","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2025.116545_bib3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the Latent Reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib4","first-page":"229","article-title":"Adverse effects of antiretroviral therapy for HIV infection","volume":"170","author":"Montessori","year":"2004","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.celrep.2025.116545_bib5","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","article-title":"Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021","volume":"27","author":"Deeks","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101412","article-title":"Immunological approaches to HIV cure","volume":"51","author":"Ward","year":"2021","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41577-018-0085-4","article-title":"Functional cure of HIV: the scale of the challenge","volume":"19","author":"Davenport","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/v16060911","article-title":"The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention","volume":"16","author":"Thavarajah","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2025.116545_bib9","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/s41591-023-02547-6","article-title":"Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial","volume":"29","author":"Gunst","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib10","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2666-5247(21)00239-1","article-title":"Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial","volume":"3","author":"Gruell","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.celrep.2025.116545_bib11","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","article-title":"Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial","volume":"28","author":"Gunst","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-04797-9","article-title":"Combination anti-HIV antibodies provide sustained virological suppression","volume":"606","author":"Sneller","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib13","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116545_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41586-022-04597-1","article-title":"Prolonged viral suppression with anti-HIV-1 antibody therapy","volume":"606","author":"Gaebler","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12977-018-0443-0","article-title":"Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers","volume":"15","author":"Landais","year":"2018","journal-title":"Retrovirology"},{"key":"10.1016\/j.celrep.2025.116545_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2144","article-title":"Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller","volume":"9","author":"Freund","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals","volume":"458","author":"Scheid","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAD.0000000000000106","article-title":"Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection","volume":"28","author":"Hraber","year":"2014","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.celrep.2025.116545_bib21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116545_bib22","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41591-024-03247-5","article-title":"Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1\/2a trial","volume":"30","author":"Julg","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/COH.0000000000000797","article-title":"Vaccinal effect of HIV-1 antibody therapy: dream or reality?","volume":"18","author":"Naranjo-Gomez","year":"2023","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.celrep.2025.116545_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/antib11030050","article-title":"Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses","volume":"11","author":"Pelegrin","year":"2022","journal-title":"Antibodies"},{"key":"10.1016\/j.celrep.2025.116545_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000948","article-title":"A Crucial Role for Infected-Cell\/Antibody Immune Complexes in the Enhancement of Endogenous Antiviral Immunity by Short Passive Immunotherapy","volume":"6","author":"Michaud","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116545_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature21435","article-title":"Early antibody therapy can induce long-lasting immunity to SHIV","volume":"543","author":"Nishimura","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41591-019-0747-1","article-title":"Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity","volume":"26","author":"Niessl","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib29","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/s41467-022-34171-2","article-title":"Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity","volume":"13","author":"Ros\u00e1s-Umbert","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116545_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib31","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1128\/JVI.00093-06","article-title":"Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses","volume":"80","author":"Deeks","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116545_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002721","article-title":"Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape","volume":"8","author":"Bar","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116545_bib33","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116545_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq4490","article-title":"Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption","volume":"15","author":"Esmaeilzadeh","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176673","article-title":"Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1","volume":"134","author":"Whitehill","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116545_bib36","doi-asserted-by":"crossref","first-page":"32066","DOI":"10.1073\/pnas.2020617117","article-title":"Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1","volume":"117","author":"Bertagnolli","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116545_bib37","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41591-021-01503-6","article-title":"Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy","volume":"27","author":"Blazkova","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib38","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1128\/JVI.75.21.10200-10207.2001","article-title":"Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection","volume":"75","author":"Montefiori","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116545_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150937","article-title":"Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection","volume":"132","author":"Mitchell","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116545_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114344","article-title":"Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption","volume":"43","author":"Mdluli","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116545_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control","volume":"12","author":"Ackerman","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116545_bib42","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.chom.2023.06.006","article-title":"Anti-V1\/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller","volume":"31","author":"Molinos-Albert","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2025.116545_bib43","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/s41467-022-29511-1","article-title":"Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers","volume":"13","author":"Molinos-Albert","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116545_bib44","unstructured":"Marino, F.E., Bellefroid, M., Krause, R., Armani-Tourret, M., Mallick, S., Papasavvas, E., Fair, M., Mounzer, K., Tebas, P., Montaner, L.J., et al. (2024). Autologous Neutralizing Antibodies Contribute to Virus Control in a Subset of PWH Treated With bNAbs. Presented at Conference on Retroviruses and Opportunistic Infections, Denver, CO, USA, March 3-6, 2024. https:\/\/www\/croiconference.org\/abstract\/autologous-neutralizing-antibodies-contribute-to-virus-control-in-a-subset-of-pwh-treated-with-bnabs\/."},{"key":"10.1016\/j.celrep.2025.116545_bib45","unstructured":"Zhuo, J., Garcia, M., Gunst, J.D., Janowska, K., Lella, M., Huang, X., Lubbeck, D., Wilson, C., Lavine, C.L., Seaman, M.S., et al. (2025). Autologous IgGs Mediate Log Reductions in HIV Infection in a PTC, Contributing to ART-Free Remission. Presented at Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, USA, March 9-12, 2025. https:\/\/www.croiconference.org\/abstract\/1344-2025\/."},{"key":"10.1016\/j.celrep.2025.116545_bib46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cell.2015.01.027","article-title":"Manipulating the Selection Forces during Affinity Maturation to Generate Cross-Reactive HIV Antibodies","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116545_bib47","doi-asserted-by":"crossref","first-page":"20077","DOI":"10.1073\/pnas.1919329117","article-title":"Optimizing immunization protocols to elicit broadly neutralizing antibodies","volume":"117","author":"Sprenger","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116545_bib48","article-title":"Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116545_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adl3755","article-title":"Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response","volume":"9","author":"Bhagchandani","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib50","article-title":"Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses","author":"Deng","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.116545_bib51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cels.2020.09.005","article-title":"Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus","volume":"11","author":"Amitai","year":"2020","journal-title":"Cell Syst."},{"key":"10.1016\/j.celrep.2025.116545_bib52","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205598119","article-title":"Two complementary features of humoral immune memory confer protection against the same or variant antigens","volume":"119","author":"Van Beek","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116545_bib53","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.immuni.2022.07.020","article-title":"Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses","volume":"55","author":"Tas","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-022-05609-w","article-title":"Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination","volume":"613","author":"Schaefer-Babajew","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib55","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.immuni.2024.05.009","article-title":"Opposing effects of pre-existing antibody and memory T cell help on the dynamics of recall germinal centers","volume":"57","author":"Schiepers","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005285","article-title":"Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes","volume":"11","author":"Heesters","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116545_bib57","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4049\/jimmunol.166.1.690","article-title":"Persistence of Infectious HIV on Follicular Dendritic Cells1","volume":"166","author":"Smith","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102332","article-title":"Persistent germinal center responses: slow-growing trees bear the best fruits","volume":"83","author":"Matz","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(00)80580-4","article-title":"Affinity Dependence of the B Cell Response to Antigen: A Threshold, a Ceiling, and the Importance of Off-Rate","volume":"8","author":"Batista","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib60","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41590-024-01844-7","article-title":"Affinity gaps among B cells in germinal centers drive the selection of MPER precursors","volume":"25","author":"Ray","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib62","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.4049\/jimmunol.1700267","article-title":"Antigen Acquisition Enables Newly Arriving B Cells To Enter Ongoing Immunization-Induced Germinal Centers","volume":"199","author":"Turner","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05573","article-title":"In vivo imaging of germinal centres reveals a dynamic open structure","volume":"446","author":"Schwickert","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib64","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.20102477","article-title":"A dynamic T cell\u2013limited checkpoint regulates affinity-dependent B cell entry into the germinal center","volume":"208","author":"Schwickert","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib65","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201254","article-title":"Modulating the quantity of HIV Env-specific CD4 T cell help promotes rare B cell responses in germinal centers","volume":"218","author":"Lee","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2022.11.032","article-title":"Continuous germinal center invasion contributes to the diversity of the immune response","volume":"186","author":"H\u00e4ggl\u00f6f","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116545_bib67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cell.2010.10.032","article-title":"Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter","volume":"143","author":"Victora","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116545_bib68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal Centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib69","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/aid.2016.0171","article-title":"Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes During Antiretroviral Therapy","volume":"33","author":"Hey-Nguyen","year":"2017","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.celrep.2025.116545_bib70","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.immuni.2021.07.015","article-title":"The unique biology of germinal center B cells","volume":"54","author":"Young","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000800","article-title":"Optimality of Mutation and Selection in Germinal Centers","volume":"6","author":"Zhang","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.celrep.2025.116545_bib72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature13300","article-title":"Clonal selection in the germinal centre by regulated proliferation and hypermutation","volume":"509","author":"Gitlin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao2602","article-title":"The microanatomic segregation of selection by apoptosis in the germinal center","volume":"358","author":"Mayer","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116545_bib74","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.173.5.1165","article-title":"In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations","volume":"173","author":"Jacob","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-024-01889-5","article-title":"B cell memory: from generation to reactivation: a multipronged defense wall against pathogens","volume":"10","author":"Syeda","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.celrep.2025.116545_bib76","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4049\/jimmunol.1701217","article-title":"Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs","volume":"201","author":"Kim","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib77","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1038\/s41467-018-05772-7","article-title":"Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes","volume":"9","author":"Moran","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116545_bib78","doi-asserted-by":"crossref","first-page":"12192","DOI":"10.1073\/pnas.1005443107","article-title":"Preferential localization of IgG memory B cells adjacent to contracted germinal centers","volume":"107","author":"Aiba","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116545_bib79","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20021110","article-title":"B Lymphocyte Memory : Role of Stromal Cell Complement and Fc\u03b3RIIB Receptors","volume":"196","author":"Barrington","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib80","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.cell.2025.04.005","article-title":"Macrophages direct location-dependent recall of B cell memory to vaccination","volume":"188","author":"Dhenni","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116545_bib81","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ni.1946","article-title":"B cell follicles and antigen encounters of the third kind","volume":"11","author":"Cyster","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib82","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.1745","article-title":"Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation","volume":"10","author":"Phan","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib83","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","article-title":"Restricted Clonality and Limited Germinal Center Reentry Characterize Memory B Cell Reactivation by Boosting","volume":"180","author":"Mesin","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116545_bib84","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.immuni.2020.09.001","article-title":"Affinity-Restricted Memory B Cells Dominate Recall Responses to Heterologous Flaviviruses","volume":"53","author":"Wong","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib85","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.adr6896","article-title":"Affinity maturation of antibody responses is mediated by differential plasma cell proliferation","volume":"387","author":"MacLean","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116545_bib86","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.20061952","article-title":"Regulation of AID expression in the immune response","volume":"204","author":"Crouch","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.it.2018.11.004","article-title":"Subcapsular Sinus Macrophages: The Seat of Innate and Adaptive Memory in Murine Lymph Nodes","volume":"40","author":"Moran","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib88","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.immuni.2024.08.017","article-title":"Conversion of vaccines from low to high immunogenicity by antibodies with epitope complementarity","volume":"57","author":"Dvorscek","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib89","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41467-023-37422-y","article-title":"mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5","volume":"14","author":"Andreano","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116545_bib90","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2024.0535","article-title":"Trade-off between the antiviral and vaccinal effects of antibody therapy in the humoral response to HIV","volume":"21","author":"Mittal","year":"2024","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.celrep.2025.116545_bib91","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41540-024-00407-8","article-title":"Modelling HIV-1 control and remission","volume":"10","author":"Vemparala","year":"2024","journal-title":"Npj Syst. Biol. Appl."},{"key":"10.1016\/j.celrep.2025.116545_bib92","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1741-7007-11-96","article-title":"Modeling the within-host dynamics of HIV infection","volume":"11","author":"Perelson","year":"2013","journal-title":"BMC Biol."},{"key":"10.1016\/j.celrep.2025.116545_bib93","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00285-018-1224-z","article-title":"Dynamics of virus and immune response in multi-epitope network","volume":"77","author":"Browne","year":"2018","journal-title":"J. Math. Biol."},{"key":"10.1016\/j.celrep.2025.116545_bib94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000103","article-title":"Dynamics of Immune Escape during HIV\/SIV Infection","volume":"4","author":"Althaus","year":"2008","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.celrep.2025.116545_bib95","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104651118","article-title":"Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody","volume":"118","author":"Meijers","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116545_bib96","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116545_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.710012","article-title":"Modeling HIV-1 Within-Host Dynamics After Passive Infusion of the Broadly Neutralizing Antibody VRC01","volume":"12","author":"Cardozo-Ojeda","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib98","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.1128\/JVI.00655-11","article-title":"Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection","volume":"85","author":"Ganusov","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116545_bib99","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1\u2013infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116545_bib100","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.00347-16","article-title":"Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies","volume":"90","author":"von Bredow","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116545_bib101","doi-asserted-by":"crossref","first-page":"E564","DOI":"10.1073\/pnas.1717765115","article-title":"Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies","volume":"115","author":"Louie","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116545_bib102","doi-asserted-by":"crossref","first-page":"29584","DOI":"10.1073\/pnas.2010256117","article-title":"A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing","volume":"117","author":"Datta","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116545_bib103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41586-024-08500-y","article-title":"Antibody prophylaxis may mask subclinical SIV infections in macaques","volume":"639","author":"Gonelli","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib104","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-022-05538-8","article-title":"Phenotypic signatures of immune selection in HIV-1 reservoir cells","volume":"614","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib105","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.celrep.2019.11.030","article-title":"Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response","volume":"29","author":"Garg","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116545_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1080853","article-title":"Amount of antigen, T follicular helper cells and affinity of founder cells shape the diversity of germinal center B cells: A computational study","volume":"14","author":"Garg","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib107","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41590-023-01559-1","article-title":"Long-term retention of antigens in germinal centres is controlled by the spatial organisation of the follicular dendritic cell network","volume":"24","author":"Mart\u00ednez-Ria\u00f1o","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib108","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41586-022-05216-9","article-title":"Long-primed germinal centres with enduring affinity maturation and clonal migration","volume":"609","author":"Lee","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib109","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","article-title":"Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance","volume":"177","author":"Cirelli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116545_bib110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116545_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120868","article-title":"Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primates","volume":"275","author":"Martin","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.celrep.2025.116545_bib112","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2012.11.022","article-title":"Translating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design","volume":"38","author":"Ferguson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib113","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1126\/science.aav5095","article-title":"Structural topology defines protective CD8+ T cell epitopes in the HIV proteome","volume":"364","author":"Gaiha","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116545_bib114","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8+ T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib116","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.omtm.2018.10.010","article-title":"Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA","volume":"12","author":"Moyo","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.celrep.2025.116545_bib117","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1038\/emi.2016.97","article-title":"Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play","volume":"5","author":"Lambour","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2025.116545_bib118","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12026-020-09159-z","article-title":"Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview","volume":"68","author":"Ali","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.celrep.2025.116545_bib119","doi-asserted-by":"crossref","first-page":"S530","DOI":"10.1093\/cid\/ciac751","article-title":"Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?","volume":"75","author":"Caskey","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2025.116545_bib120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0381","article-title":"The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen","volume":"10","author":"Havenar-Daughton","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116545_bib121","doi-asserted-by":"crossref","first-page":"20216","DOI":"10.1073\/pnas.0909775106","article-title":"Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire","volume":"106","author":"Glanville","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.celrep.2025.116545_bib122","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1126\/science.aad9195","article-title":"HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen","volume":"351","author":"Jardine","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116545_bib123","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2016.02.010","article-title":"Complex Antigens Drive Permissive Clonal Selection in Germinal Centers","volume":"44","author":"Kuraoka","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2025.116545_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl5842","article-title":"Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses","volume":"6","author":"Feldman","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2025.116545_bib125","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time","volume":"271","author":"Perelson","year":"1996","journal-title":"Science"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725013166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725013166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:30:18Z","timestamp":1776918618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725013166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":125,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2211124725013166"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116545","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.05.641732","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116545"}}